((自动化翻译由路透提供，请见免责声明 ))
12月10日 - ** 制药商 Cumberland Pharmaceuticals 股价盘前上涨 ~108% 至 2.57 美元
** CPIX 周一表示，美国 FDA 批准了该公司治疗扑热息痛过量的补充新药申请。
** 对乙酰氨基酚（化学名称为对乙酰氨基酚）是导致美国急性肝衰竭的主要原因 - CPIX
** 这种名为 Acetadote 的药物简化了用药剂量，降低了用药错误的风险，同时还能保持疗效 - co
** 截至上次收盘，该公司股价已累计下跌 30.7
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.